Recently, mac-2-binding protein glycan isomer (M2BPGi) has been shown to enhance the aggressiveness of HCC via the activation of the mTOR signaling pathway [94], harboring potential as a minimally invasive biomarker. This evidence concerns the gene MTOR and hepatocellular carcinoma.